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K.R. Aryal and H. Al-khaffaf*Department of Vascular Surgery, Burnley General Hospital, Burnley, Lancashire BB10 2PQ, UKObjectives. To quantify the risk of venous thromboembolism (VTE) following air travel and assess methods of prevention.
Design. Review of literature.
Methods. We reviewed Pubmed, Medline, Embase and Cochrane Databases for studies that have assessed the risk of VTE
associated with air travel.
Results. There is an association of VTE with air travel with pooled odds ratio of 1.59 (confidence interval 1.04–2.43) from
three case control studies and relative risk of 2.93 (confidence interval 1.5–5.58) from two controlled cohort studies. The
incidence of symptomatic pulmonary embolism (PE) is extremely low but there is substantial increase when the distance
travelled is more than 5000 mile (1.5 PE per million passengers) or time of flight is more than 8 h duration (2.57 PE per
million passengers). The quantitative risk of lower limb venous thrombosis in high-risk subjects is 5% per flight and 1.6%
per flight for low risk subjects following long haul flights. All six randomised trials to test the below knee compression
stockings with ankle pressures of 14–30 mmHg have shown reduction in lower limb venous thrombosis.
Conclusion. VTE is more common in those with additional risk factors when the risk is about 5% per air travel for long haul
flights. Class I or II below knee compression stockings are effective in the prevention of lower limb venous thrombosis.Keywords: Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism; Air travel; Long haul flight; Lower limb
venous thrombosis.Introduction
Over the last few years there has been a lot of interest
by the media, air-line industry and public health
institutions in the problem of venous thromboembo-
lism (VTE) following long haul flights. In 2001 the
Guardian reported the death of a 27-year-old British
woman as a result of pulmonary embolism after long
flight from Australia to London.1 The World Health
Organisation (WHO) in a press release in Geneva after
consultation with international experts and airline
industry in March 2001 stated that there is probably
some association between air-travel and venous
thrombosis but the evidence is weak and further
research is needed to quantify the risk.2,3
The relationship between prolonged sitting and
pulmonary embolism (PE) was reported as early asing author. H. Al-khaffaf, Department of Vascular
Floor Pennine House, Burnley General Hospital,
ashire BB10 2PQ, UK.
: alkhaffaf@hotmail.com
0187 + 13 $35.00/0 q 2005 Elsevier Ltd. All rights reser1940. There were many cases of PE in Britons forced to
remain seated in cramped conditions for hours during
the Second World War.4 Homans first reported a case
of deep vein thrombosis (DVT) after a 14-h flight in a
physician in 1954.5 Since then various studies, first in
the form of case reports and case control studies and
more recently in the form of randomized controlled
trials (RCTS) have been published to support the
association between air-travel and VTE.
The aim of this review is to quantify the risk of VTE
following air-travel. We also wanted to assess the
methods of prevention of VTE following long haul
flights.Methods
Literature search was carried out using key words and
medical subject heading (MeSH) terms ‘deep vein
thrombosis’, ‘venous thromboembolism’, ‘pulmonary
embolism’, ‘air travel’, ‘economy class syndrome’Eur J Vasc Endovasc Surg 31, 187–199 (2006)
doi:10.1016/j.ejvs.2005.08.025, available online at http://www.sciencedirect.com onved.
K. R. Aryal and H. Al-khaffaf188and ‘long haul flight’ on Pubmed, Medline, Embase
and Cochrane databases limited to human subjects (in
November 2004). Full text of all relevant papers in
English language was retrieved. Further papers
identified from the reference list of major articles
were cross-referenced by hand.Inclusion criteria
Thrombosis of deep, superficial or muscle veins of the
lower limbs and PE have been used to mean VTE.
Thrombosis of the cerebral and subclavian veins has
not been considered in this review although there may
be some association between these and air travel.
Different types of thromboembolism have been
specified as far as possible.
Flights with duration of more than 6–7 h have been
considered as long haul flights. These times are spent
inside the aeroplane and do not include time spent in
transit or stop-over. For final analysis only case control
studies, controlled cohort, randomized trials and
incidence studies have been included. Case reports
and case series have been excluded. Level of evidence
obtained from the studies has been stated according to
recommendations for grading evidence by Scottish
Intercollegiate Guidelines Network Grading Review
Group.6Statistics
Pooled estimates of odds ratios from case control
studies and pooled estimates of relative risks from
controlled cohort studies were expressed as fixed-
effect model according to Mantel and Haenszel (due to
absence of heterogeneity in the studies), using
Statsdirect Package software.Results
Forty-three studies relevant to this review were found
18 of which met the inclusion criteria. Of these, five
were case control studies, two controlled cohort and
eight randomized controlled trial studies (three of
them with two trials in each study) and three incidence
studies for symptomatic pulmonary embolism. The
remaining studies although quoted here in the text
have not been included for final analysis because they
did not have much strength in terms of the level of
evidence.Eur J Vasc Endovasc Surg Vol 31, 2 2006Incidence of deep vein thrombosis in
the general population
The reported incidence of deep vein thrombosis (DVT)
in the general population is around 1–2 person per
1000 population per year. One to two percent of those
who have DVT may develop PE many of which may
be fatal.7–9Difficulty in recruiting subjects for venous
thromboembolism studies in long haul flights
Meaningful comparison between the general popu-
lation and those who are taking long haul flight is
difficult. People taking long haul flights are healthier
and have lesser risk than the general population and,
therefore, are not a true sample for comparison. In
addition to that, many high-risk patients may not take
air travel due to health reasons. The total number of
recruits necessary for meaningful comparison is large.
A correspondence letter in the Lancet suggested that
2500 airline passengers would have to be studied to
confirm a significant increase in the DVT compared
with controls.10 This sample size was based on the
power calculation with the 1 per 1000 incidence of
DVT in the general population and extrapolating it on
the 24-h flight.10 Furthermore, performance of necess-
ary investigations for assessment of VTE needs
considerable resource and time. D-Dimer assay,
though highly sensitive, has a false positive rate for
other conditions undermining its specificity.11,12
Although, venography has been considered as gold
standard by many authors, it is invasive and may not
be acceptable to many recruits.13 Therefore, all studies
have used duplex scan for the diagnosis of lower limb
venous thrombosis. Although it is well known that
duplex scan has a sensitivity and specificity of 97% for
proximal DVT, the sensitivity decreases for distal DVT
when compared with venography.12,14 Another
problem faced in such studies is the number of drop
outs, even after the subjects have agreed to take part in
the study, due to flight connection problems and,
therefore, analysis carried out on the remaining
subjects may not be a true indicator of the overall
subjects taking part in the study. The timing of
assessment is an equally difficult issue and the
formation of clot may be many days after the
passengers leave the flight. Many airlines may claim
that thrombosis detected after the flight may have
been present before the passenger boarded the flight.
Ideally, all studies should have duplex scan before and
after the flight. Despite these limitations there have
been numerous studies related to air travel and VTE.
Venous Thromboembolism and Air Travel 189Pathogenesis of thromboembolism in long haul flights
Virchow’s classic triad15 of venous stasis, vessel wall
damage and hypercoagulable state of blood remains
true for the formation of thrombus. Prolonged sitting
causes venous stasis and is the triggering factor.
Significant fluid retention (O1 l) in the lower leg was
noted in long haul air travellers which may promote
venous compression16 and another study model
showed significant increase in the ankle, calf and leg
circumference after 6 h simulated flight.17 The press-
ure by the edge of the seat to the back of the leg,
exaggerated by crossing of the legs in the narrow
cramped condition of the economy class seats may
damage the endothelium of the leg veins. There have
been reports of an increase in platelet count and
platelet packing after 6 h of simulated flight creating
hypercoagulable state.17 Additional factors such as
dehydration due to alcohol intake, low fluid intake
and dry atmosphere of the aeroplane cabin increases
the risk of haemoconcentration.18 Decreased oxygen
tension and low ambient pressure in the aeroplane
have been shown to impair fibrinolysis and to induce
activation of coagulation.19,20Venous thromboembolism following long haul flights:
stratification of risk
Various factors influence the formation of VTE. Air
passengers with additional risk factors are likely to be
at higher risk. Passengers with out any known clinical
disease and not on any medical treatment are low risk
subjects. High risk individuals include those with
previous history of DVT, hypercoagulable states such
as factor V Leiden mutation, obesity, limitation of
mobility due to bone or joint problems, neoplastic
disease with in the previous 2 years, hormone
replacement therapy, diabetes, hypertension, cardiac
failure, other cardiovascular disease, large varicose
veins and recent trauma.21,22Case reports and case series
Until mid to late 90s, most published literature was in
the form of case reports or case series. Symington and
Stack coined the term ‘Economy class syndrome’ after
looking at 182 cohorts of pulmonary embolism
patients. They found out that out of eight passengers
in various modes of prolonged travel three had
travelled between Britain and India or Portugal in
the economy class of the aeroplane.23 This was further
strengthened by Cruickshank et al. (one of the subjects
being himself) who reported six cases of pulmonaryembolism after an air travel.24 In a post mortem
examination of 61 aeroplane sudden deaths referred to
the coroner arriving at Heathrow airport, Sarvesvaren
found that 11 (18%) were due to pulmonary embolism
and all had flights of more than 6 h duration.25 Mercer
and Brown reviewed the records of 134 pulmonary
embolism cases and checked for a history of air travel
in 66 of them. Thirty-three (50%) of those 66 had
history of air travel for 4 h or more and inferred that air
travel was the most common risk factor for VTE.26 In
Honolulu, Hawaii out of 254 patients admitted with
DVT and or PE, 44 (17.3%) had developed their
symptoms during or after air travel.27Case control studies
Five case control studies have been published. In these
studies, comparisons were made between patients
having VTE with those not having VTE and history of
long distance travel (in two studies) or air travel (in
three studies) was recorded (Table 1).
Ferrari et al. compared the venous thromboembolic
patients in their cardiology department with
other patients with out venous thromboembolism
(160 patients in each group). They found that recent
journey of more than 4 h duration (whatever means of
transport) was found in 39 cases of thromboembolic
group and 12 cases of control group with an odds ratio
of 3.98. However, in this study only nine of 39 patients
had travelled by air, with a mean duration of 5G0.7 h.
Of the remaining patients, 28 travelled by car and two
by train.28 Samama et al. compared 494 DVT case
patients and 494 control patients with influenzal or
rhinopharyngeal syndrome. All these were medical
patients (those who did not have surgery or plaster of
Paris application). There was a history of long distance
travel in 62 (12.5%) of the DVT group and 31 (6.3%) of
the control population with and odds ratio of 2.35.29
From these two studies there appears to be strong
association between travel and VTE (pooled estimate
of odds ratio 2.6, 95% CI 1.79–3.79) (Table 1). Although
in these studies all subjects did not travel by aeroplane,
it emphasizes the point that prolonged sitting in
cramped conditions for long periods increases the
risk of VTE.
Kraaijenhagen et al.30 took a cohort of 788 suspected
cases of DVT and compared 186 of confirmed cases of
DVT with 602 controls without DVT and found out a
history of air travel in four of DVT group and 13 of
non-DVT group with and odds ratio of 1. There was
dissimilar number of patients in the two groups and
most patients travelled for less than 5 h duration.30
Arya et al. from a cohort of 568 cases of suspected DVTEur J Vasc Endovasc Surg Vol 31, 2 2006
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Eur J Vasc Endovasc Surg Vol 31, 2 2006compared 185 confirmed cases of DVT with 383 cases
without DVT in terms of air travel. There was no
significant link between air travel and DVT in this
cohort with an odds ratio of 1.3. However, when one
additional risk factor was present the risk of DVT was
increased in air travellers (odds ration 3.0 confidence
interval 1.1–8.2).31 A more recent study by Martinelli
et al.32 showed that history of air travel was more
common in patients with VTE compared with controls
with odds ratio of 2.1. From the pooled estimate of
odds ratio for these three studies there appears to be
stronger association between VTE and air travel (odds
ratio 1.59) (Table 1).Controlled cohort studies
Two controlled cohort studies have been published in
which air passengers were compared with control
group of non-passengers for presence of VTE. Schwarz
et al. in a prospective controlled pilot study examined
160 air passengers with 160 age and sex matched non-
travelling volunteers and assessed lower limb venous
thrombosis on compression ultrasound, which was
present in 2.5% of air passengers and 0.6% of non-
travelling volunteers.33 In another larger study by the
same group comparing 964 passengers with 1213 non-
passengers, there were 2.8% thrombotic complications
(DVT and muscle vein thrombosis) in the passenger
group compared with 1% in the control group.34 This
1% in the control group is high and it may be because
large number (35.7%) of them had varicose veins and
many had additional risk factors including elevated
factor VIII level in 30%. Pooled estimate of the relative
risk from these two studies gives relative risk of 2.93
with strong association between air travel and VTE
(Table 2).Incidence of symptomatic pulmonary embolism in air
travellers
Three studies looking at symptomatic cases of PE in
the referral hospitals from three busy airports of Paris,
Madrid-Barajas and Sidney have been published. One
looked at the distance traveled and the other two at
duration of the flight (Table 3). There was substantial
increase in PE incidence when the distance travelled is
more than 5000 km or of more than 8 h duration. In
Paris, the overall incidence was only 0.39 person per
million passengers but once the distance travelled
was more than 5000 km the incidence was 1.5 per
million passengers. This increased further for dis-
tances above 10,000 km (4.77 pulmonary embolism per
million passengers).35 Similarly in Madrid-Barajas
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Venous Thromboembolism and Air Travel 191the incidence was 1.65 per million for duration of more
than 8 h.36 In Sydney airport where all the analysed
flights were of more than 9 h duration the incidence of
PE embolism was 1.65 per million passengers.37
The incidence of pulmonary embolism appears to
be low based on the above figures. However, all these
are cases of symptomatic pulmonary embolism and
this may only indicate the tip of the iceberg. All
asymptomatic cases, those who had DVT with out
pulmonary embolism, those who had symptoms after
some days following the flight or those who did not
attend because of the connection problems have been
missed.Incidence of lower limb venous thrombosis from recent
randomised or controlled studies
LONg FLighT Thrombosis (LONFLIT) study was
designed to evaluate the incidence of deep vein
thrombosis after long haul flights and preventative
measures. It published its first results in 2001 and
showed that in high-risk subjects the incidence may be
as high as 5% but in low risk subjects the incidence was
zero.22Passengers with additional risk factors
All subjects with additional risk factors have higher
risk of thrombosis. McQuillan et al.38 showed that the
most common risk factors were oestrogen, previous
history of deep vein thrombosis and factor V Leiden.
At least one additional risk factor was present in more
than 80% of the patients who developed VTE with in
30 days of travel. Similarly, in another study by
Paganin et al.39 of 46 cases of VTE, 38 (82%) had
additional risk factors. History of previous VTE, recent
trauma, presence of varicose veins, obesity, immobility
during flight and cardiac disease was significantly
higher in the thrombotic group compared with
controls. In another study by Hosoi et al. of 101
patients with DVT 15 had history of travel of whom 13
(87%) had additional risk factors.40
In all five studies in high risk subjects in LONFLIT
series the incidence of lower limb venous thrombosis
for those not receiving any prophylaxis ranged from
4.5 to 7.6% (overall 5%) per long haul flight22,41–43
(Table 4). Although there was no risk stratification in
Scurr’s study44 the 10% incidence of DVT per long
haul flight in the control group was high and it could
be because most subjects were more than 50 years of
age and median duration of travel being 24 h (? High-
risk).Eur J Vasc Endovasc Surg Vol 31, 2 2006
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Eur J Vasc Endovasc Surg Vol 31, 2 2006Passengers with no (low) risk factor
Out of six studies involving the low medium risk
groups in LONFLIT studies three did not have any
lower limb venous thrombosis. Three studies showed
it to be 3.3, 4.2 and 6%, respectively45–47 (Table 4).
Pooled data from these six studies shows the risk to be
1.6% per long haul flight.
In the New Zealand Air Traveller’s Thrombosis
(NZATT) study 878 passengers with flight duration of
at least 10 h with low to moderate risk were included.
All had D-Dimer estimation. Only 112 cases with
raised D-Dimer underwent compression ultrasono-
graphy. There were only nine cases of venous
thromboembolism (four pulmonary embolism and
remaining were deep vein thrombosis).48 But 17% of
the subjects were using compression stockings and
31% were using aspirin. The use of D-Dimer as a
screening tool in this study may have missed many
patients with normal D-Dimers. This assay though
highly sensitive in suspected cases of VTE does not
appear to have reliable predictability for flight related
DVT. None of 12 ultrasound detected DVTs in Scurr’s
paper had raised D-Dimer.44 Of 27 DVT or isolated calf
muscle vein thrombosis, only 11 had raised D-Dimers
in Schwarz’s paper.34 There was no significant
difference in D-Dimer level between ultrasound
detected DVT and those without DVT in two of the
LONFLIT studies.42,43 The remaining LONFLIT
studies do not mention any thing about D-Dimer
assay.22,41,45–47LONg FLIghT (LONFLIT) studies
LONg FlighT Thrombosis (LONFLIT) study was
originally set up to detect the incidence of lower
limb venous thrombosis following long haul flights.
LONFLIT 1 looked at the incidence in the low risk and
high-risk groups.22 LONFLIT 2 study evaluated the
role of below knee graduated elastic compression
stockings in high-risk subjects.22 The LONFLIT 3
study41 evaluated aspirin and low molecular weight
heparin (LMWH) in high-risk subjects for reduction of
DVT.
The LONFLIT 4 study45–47 has three different
publications relating to the thrombosis and air travel.
All were in low and medium risk groups. In the first
study45 Flight socks, Scholl, UK below knee com-
pression stocking with ankle pressure of 14–17 mmHg
were used. There was a reduction in DVT and oedema
in the stocking group. In the second paper45 Sigvaris,
Traveno, Ganzoni, below knee graduated compression
stocking with ankle pressure of 12–18 mmHg were
Table 4. Quantitative risk for lower limb venous thrombosis in air travellers with out any prophylaxis
No. Author Year Total no. of
subjects
Total no. of
subjects with
thrombosis
Percentage of
venous throm-
bosis
Level of
evidence
Flight duration Assessment tool for
thrombosis
1 Scur J.H. et al.44 2001 116 control 12 10 IC O 8 h Duplex ultrasound
2 Belcaro G. et al.22
(LONFLIT 1)
2001 389 high risk 13 DVT* 4.9 IIC 12.4 h Duplex ultrasound
6 SVT†
355 low risk None 0
3 Belcaro G. et al.22
(LONFLIT 2)
2001 422 control,
high risk
19 DVT* 4.5 IC 12.4 h Duplex ultrasound
4 Caserone M.R. et al.41
(LONFLIT 3)
2002 82 high risk
control
4 4.82 IC ? Duplex ultrasound
5 Belcaro G. et al.45
(LONFLIT 4 Concorde
oedema SSL)
IC
Part 1 2002 179 low, med
risk control
4 DVT* 2.2 7–8 h Duplex ultrasound
2 SVT† 1.1
Part 2 2002 143 low, med
risk, control
3 DVT* 2.1 11–12 h Duplex ultrasound
3 SVT† 2.1
6 Caserone M.R.46
(LONFLIT 4 ECO-
TRAS)
IC
Part 1 2003 98 low medium
risk control
None 0 7–8 h Duplex ultrasound
Part 2 2003 71 low risk
control
None 0 11–12 h Duplex Ultrasound
7 Caserone M.R.47
(LONFLIT 4 Concorde
DVT and oedema
study)
IC
Part 1 2003 74 low medium
risk control
None 0 7–8 h Duplex ultrasound
Part 2 2003 66 low medium
risk control
2 DVT 3 11–12 h Duplex ultrasound
2 SVT 3
8 Cesarone M.R.42
(LONFLT-FLITE)
2003 92 high risk
control
5 DVT 5.4 IC 7–8 h
2 SVT 2.2
9 Belcaro G.43 (LONFLIT
5 JAP)
2003 102 high risk 6 DVT 5.8 IC 11–12 h
Total 1087 high risk 55 5
986 low risk 16 1.6
116 risk not
known
12 10
* DVT, deep vein thrombosis.
† SVT, superficial vein thrombosis.
V
e
n
o
u
s
T
h
ro
m
b
o
e
m
b
o
lis
m
a
n
d
A
ir
T
ra
v
e
l
1
9
3
E
u
r
J
V
asc
E
n
d
o
v
asc
S
u
rg
V
o
l
31,
2
2006
Table 5. Prevention of thrombo-embolic complications, results from randomised trials
No. Author Type of
study
Level of
evidence
Prophylaxis
measure
Assessment
tool for
thrombosis
Number of subjects No. of thrombosis subjects (%) P value Remarks Drop outs
Control Intervened Control Intervened
1 Scur J.H.
et al.44
Random-
ised trial
IC Class I
below knee
com-
pression
stocking pr
20–
30 mmHg
Duplex scan 116 115 12 (10%) 0 (0%) All
asympto-
matic
2 Belcaro G.
et al.22
(LONFLIT
2)
Random-
ised trial
IC Below knee
stocking
ankle pr
25 mmHg
Duplex scan 422 411 19 (4.5%) 1 (0.24%) !0.02 All high
risks
? No
mention
3 Cesarone
M.R. et al.41
(LONFLIT
3)
Random-
ised trial
IK Aspirin,
LMWH*
Duplex scan 83 84 82 4 (4.82%) 3 (3.6%) 0 !0.02 All high
risk
17, 16, 18
respect-
ively
4 Belcaro G.
et al.45
(LONFLIT
4 Concorde
oedema
SSL)
IC
Part 1 Random-
ised trial
Below knee
flight socks
14–
17 mmHg
Duplex scan 179 179 6 (3.35%) 0 !0.05 Low, med
risk flight
duration
7–8 h
5 and 9
Part 2 Random-
ised trial
Below knee
flight socks
14–
17 mmHg
Duplex scan 136 135 6 (4.2%) 0 !0.005 Low, med
risk, flight
duration
11–12 h
6 and 8
5 Cesarone
M.R. et al.46
(LONFLIT
4) EcoTraS
Part 1 Random-
ised trial
IC Below knee
Traveno
stockings
12–
18 mmHg
Duplex scan 98 97 0 0 Low, med
risk, 7–8 h
10, 6
Part 2 Random-
ised trial
IC As in part 1 Duplex scan 71 75 0 0 low, med
risk, 11–
12 h
11, 8
6 Cesarone
M.R. et al.47
(LONFLIT
4 Concorde
DVT† and
oedema)
IC
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Venous Thromboembolism and Air Travel 195used. In both part 1 and part 2 there was no DVT in
either the control or the stocking group but there was a
reduction in oedema in the stocking group. The third
of the LONFLIT 4 papers47 looked at Kendall travel
socks (Tyco Healthcare, Mansfield, USA) with ankle
pressure of 20–30 mmHg and showed reduction both
in DVT and oedema in the stocking group.
LONFLIT-FLITE study42 looked at the effect of
profibrinolytic FLITE tablets (pinokinase) on high-risk
subjects and in LONFLIT 5 JAP study,43 Flight sock,
Scholl, UK was used with ankle pressure of
14–17 mmHg. Both studies showed reduction in DVT.Prevention of thrombo-embolic complications in long haul
flights
Some of the simple measures should be advised to
passengers. These include drinking plenty of fluids (one
glass of water at least every 2 h) but not much alcohol to
prevent dehydration. Tight clothing should be avoided.
They should be advised not to keep their bag in front of
seats to limit stretching the legs and should stretch their
legs at least every hour for 2 min. They should be
encouraged to be mobile (3 min every hour).22
Of the 11 randomised trails published so far to see
the efficacy of various measures nine were graduated
below knee compression stockings with ankle press-
ures ranging from 14 to 30 mmHg.22,43–47 Among the
remaining two, one tested LMWH and aspirin41 and
the other tested profibrinolytic agent pinokinase called
FLITE41 (Table 3).
Among the studies that have tested stockings there
was a reduction in lower limb venous thrombosis in
six trials to 0.24 and 0.98% in two instances22,43 and 0%
in the remaining four trials.44,45,47 Three trials had 0%
lower limb venous thrombosis in the control group
and there was no advantage in this respect45,46 but
there was reduction in leg oedema in these subjects.
LMWH single dose injection before travel reduced
the incidence from 4.2 to 0%.41 However, the incidence of
DVT in subjects taking aspirin in this trail was 3.6%. The
dose of aspirin used rather high (400 mg once daily for
3 days) and 13% in this group experienced gastrointes-
tinal side effects.41 Another trial looking at the effect of
profibrinolytic agent FLITE showed reduction of lower
limb venous thrombosis from 7.6 to 0%.43
Based on these studies, below knee graduated
compression stockings class I or II seem to reduce
the incidence of DVT and oedema in long haul flights.
Low molecular weight heparin is probably useful and
so is antifibrinolytic agent but more research is
needed. Aspirin has not been useful and it caused
gastro intestinal symptoms in stead (Table 5).Eur J Vasc Endovasc Surg Vol 31, 2 2006
K. R. Aryal and H. Al-khaffaf196Economy class vs business class traveller and
thrombo-embolic complications
BEST (Business vs Economy class Syndrome as a cause
of venous Thrombosis) study49 from South Africa tried
to address this issue with 180 passengers in the
business class and 719 in the economy class. Elevated
D-Dimers were present in 12% business class and 7%
economy class passengers, which was measured in all
subjects. However, duplex ultrasound was optional
and was only performed in 86-business class and 348
economy class subjects none of who had venous
thrombosis. The limitation of this study was that there
were dissimilar number of passengers in the two
groups because they could not continue to recruit their
business class passengers due to cost constraints to
reach similar number to economy class passengers and
duplex scan was not done in all.
Symptomatic vs asymtomatic deep vein thrombosis
From the published studies to date the majority
of lower limb venous thrombosis were asymptomatic
(Table 6). But in all these studies the passengers had
duplex scan to rule out thrombi before they boarded
the flight. Repeat scan was performed to evaluate
the presence of thrombi on completion of the flight
and further scans were not carried out. The papers
describing symptomatic VTE following air-travel
have not had duplex evaluation before the travel
and it raises the question if they had preexisting
thrombi before they boarded the flight.Site of lower limb venous thrombosis
Table 7 illustrates the site of lower limb venous
thrombosis from the available papers. Most ofTable 6. Symptomatic vs asymptomatic lower limb venous thrombos
Author Total no. of thrombosis
Schwarz T.33 4 ICMVT*
Schwarz T.34 20 ICMVT*
7 DVT†
Scurr J.H.44 12 DVT†
Cesarone M.R.41 7 (control and aspirin gr
Belcaro G.45 (LONFLIT 4 Concorde
oedema SSL)
Part 1 6
Part 2 6
Cesarone M.R.47 (LONFLIT Concorde
DVT and oedema study)
Part 2 2 DVT†
Cesarone M.R.42 (LONFLIT-FLITE) 7
Belcaro G.43 (LONFLIT 5 JAP) 6 DVT†
* ICMVT, isolated calf muscle venous thrombosis.
† DVT, deep venous thrombosis.
Eur J Vasc Endovasc Surg Vol 31, 2 2006the DVT were in the calf segment. There were a few
muscle vein thrombosis. The actual importance of
muscle vein thrombosis is still unclear although some
authors have claimed that it is a marker of DVT.34Aisle seat vs non-aisle seat traveller and occurrence
of venous thrombosis
Some of the LONFLIT studies have reported higher
incidence of DVT in central or window seat passengers
than aisle seat passengers (Table 8) implying that aisle
seats had protective effect in relation to the develop-
ment of venous thrombosis.22,41,45
Is the female sex more prone to thrombo-embolic
complications after long haul flights?
There was no difference in the development of DVT
in male and female sexes in LONFLIT 3, LONFLIT 4
Concorde oedema-SSL study both part 1 and 2.
Among females, three of seven females in LONFLIT
3 and all six in part 1 and 2 of LONFLIT 4 Concorde
oedema-SSL study were taking oral contraceptive
pills.40,44 Another study has shown that the use of
oral contraceptive with air travel increases the chance
of thrombosis by 14 fold.32Timing of deep vein thrombosis following air travel
The risk of VTE has been shown to be highest with
in 2 weeks of a long haul flight.50 In this study,
Kelman et al. looked at 153 Australian citizens
admitted to Hospitals with VTE with in 100 days of
arrival on an international flight. Forty-six events
occurred with in 14 days of the flight. The observed
number of cases with in 2 weeks of arrival
significantly exceeded the number expected underis
Asymtomatic (No.) Symptomatic (No.)
4 0
19 1
5 2
12 0
oup combined) 4 3
6 0
5 1
2 0
7 0
6 0
Table 7. Site of lower limb venous thrombosis
Author Total of subjects Total no. of lower limb
venous thrombosis
Site of deep vein
thrombosis
Remarks
Scur J.H. et al.44 116 12 DVT All calf
Belcaro G. et al.22 (LONFLIT 1) 389 high risk 13 DVT 5 proximal (femoral)
6 SVT 8 distal (popliteal)
Belcaro G. et al.22 (LONFLIT 2) 422 high risk 19 DVT Site not mentioned Femoral and popliteal
vein scanned
Caserone M.R. et al.41
(LONFLIT 3)
82 high risk 4 DVT Site not mentioned Femoral and popliteal
vein scanned
Belcaro G. et al.45
Part 1 179 low, med risk 4 DVT 2 popliteal
2 SVT 2 proximal tibial
Part 2 143 low, med risk 3 DVT 3 popliteal
Cesarone M.R. et al.47
Part 2 66 low medium risk 2 DVT 2 popliteal
2 SVT
Cesarone M.R.42
(LONFLT-FLITE)
92 high risk 5 DVT Site not mentioned Scanned veins fem,
pop or tibial
2 SVT
Belcaro G.43 (LONFLIT 5 JAP) 102 high risk 6 DVT 3 superficial femoral
2 popliteal
1 soleal
Schwarz T. et al.33 160 4 ICMVT All soleal muscle vein
Schwarz T. et al.34 964 20 ICMVT 17 soleus muscle vein
7 DVT 3 gastrocnemius
muscle vein
5 peroneal or tibial
posterior veins
2 popliteal vein
DVT, deep vein thrombosis; SVT, superficial vein thrombosis; ICMVT, isolated calf muscle vein thrombosis.
Venous Thromboembolism and Air Travel 197the assumption of uniform distribution over
the 0–100 days after arrival.Conclusion
There appears to be an association between long haul
flights and VTE. The incidence of lower limb venous
thrombosis in low risk passengers is about 1.6% while
in those with additional risk factors is about 5%. Below
knee graduated compression stocking with ankle
pressure ranging from 14 to 30 mmHg (class 1 or 2)Table 8. Incidence of lower limb venous thrombosis in non-aisle sea
Study Author Year
LONFLIT 1 Belcaro G. et al.22 2001
LONFLIT 2 Belcaro G. et al.22 2001
LONFLIT 3 Cesarone M.R. et al.41 2002
LONFLIT 4 Concorde
oedema SSL
Part 1 Belcaro G. et al.45 2002
Part 2 Belcaro G. et al.45 2002
LONFLIT 4 Concorde
DVT oedema
Part 2 Cesarone M.R.47 2003
LONFLI-FLITE Cesarone M.R.42 2003
LONFLIT 5 JAP Belcaro G.43 2003
* DVT, deep vein thrombosis.have been shown to be effective in reducing lower limb
venous thrombosis (level of evidence 1C). They are
also effective in reducing oedema of the legs in low risk
subjects. Their role in the prevention of pulmonary
embolism needs further research. Similarly, the role of
low molecular weight heparin and profibrinolytic
agents either singly or in combination with stockings
also needs further research. The idea that aisle seat
passengers are more protected than the window or
middle seat passengers is rather interesting and may be
a reflection of the fact that these patients are freer to
move in the aisle than other passengers. The advice thatt passengers from LONFLIT studies
Total no. of thrombosis Total no. of thrombosis
in non-aisle seat
19 18
19 DVT* All 19
7 DVT* 6
6 6
6 4
4 Not mentioned
7 Not mentioned
7 Not mentioned
Eur J Vasc Endovasc Surg Vol 31, 2 2006
K. R. Aryal and H. Al-khaffaf198passengers should drink plenty of fluid, be mobile in
the aeroplane, stretch their legs and avoid tight
constricting clothes is based on common sense and
indirect conclusion rather than direct evidence and also
needs further research.
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